Impact of a Direct Oral Anticoagulant Population Management Tool on Anticoagulation Therapy Monitoring in Clinical

Daniela Valencia1, Patrick Spoutz2, Jaclyn Stoppi1

  • 11 West Palm Beach VA Medical Center, FL, USA.

Insights

A new DOAC Population Management Tool (PMT) improves direct oral anticoagulant (DOAC) monitoring. This strategy is more effective and efficient than traditional anticoagulation clinics (AC), leading to more interventions and better patient care.

Area of Science:

  • Pharmacology
  • Clinical Pharmacy
  • Health Informatics

Background:

  • Optimal long-term monitoring for direct oral anticoagulants (DOACs) remains undefined.
  • Historically, patients on DOAC therapy were managed through scheduled appointments at anticoagulation clinics (AC).

Purpose of the Study:

  • To evaluate the efficacy and efficiency of a DOAC Population Management Tool (PMT) compared to traditional AC practices.
  • The study aimed to determine if the PMT could improve intervention rates and reduce monitoring time.

Main Methods:

  • Patients were divided into two groups: DOAC PMT (flagged for potential dosing issues or valve replacement history) and AC (routine follow-up).
  • Interventions were prospectively recorded and compared between the two groups.
  • Efficiency was measured by the time required to generate an intervention.

Main Results:

  • The DOAC PMT group yielded 0.55 interventions per flag reviewed, compared to 0.20 interventions per patient encounter in the AC group (P < 0.001).
  • The time to generate an intervention was significantly shorter in the DOAC PMT group (16 minutes) versus the AC group (64 minutes).

Conclusions:

  • A population-based approach using the DOAC PMT is more effective and efficient for monitoring DOAC therapy.
  • This strategy enhances opportunities for timely interventions and improves clinic access for patients needing immediate attention.

Related Concept Videos

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants01:18

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants

Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
2.3K
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
1.8K
Esophageal Perforation-II: Clinical Manifestations and Management01:28

Esophageal Perforation-II: Clinical Manifestations and Management

Esophageal perforations manifest in various clinical forms, influenced by factors such as the perforation's cause and location (cervical, intrathoracic, or intra-abdominal), the extent of contamination, and potential injury to adjacent mediastinal structures. The timing between the perforation occurrence and treatment initiation also affects the clinical presentation.
Clinical Manifestations:
706
Barrett Esophagus-II: Clinical Manifestations and Management01:21

Barrett Esophagus-II: Clinical Manifestations and Management

Individuals with Barrett's esophagus are often asymptomatic, but they may experience symptoms commonly associated with GERD, such as heartburn and acid regurgitation. Additional symptoms can include difficulty swallowing, chest pain, unintentional weight loss, blood in the stool (which may appear black, tarry, or bloody), and episodes of vomiting.
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure...
1.0K
Esophageal Varices-II: Clinical Features and Management01:28

Esophageal Varices-II: Clinical Features and Management

Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
547
Gastritis III: Clinical Manifestations and Management01:23

Gastritis III: Clinical Manifestations and Management

The clinical manifestations of gastritis can vary depending on the cause and type of gastritis, but some common symptoms may include the following.
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
1.2K